Dose-response Study to Evaluate Safety, Efficacy, and Pharmacokinetics of PF-00217830 Compared With Placebo in Acute Exacerbation of Schizophrenia
Clinical trial NCT00580125 · COMPLETED
Trial details
- NCT number
- NCT00580125
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-11-01
- Primary completion
- 2008-09-01
- Enrollment
- 164
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.